These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


524 related items for PubMed ID: 9794721

  • 1. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
    Liu Y, Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M.
    J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
    [Abstract] [Full Text] [Related]

  • 2. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
    López RM, Pérez T, Castillo C, Castillo MC, Castillo EF.
    Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M.
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [Abstract] [Full Text] [Related]

  • 4. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD, Friberg P, Adams MA.
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O, Gaudet E, Blanc J, Ponchon P, Elghozi JL.
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [Abstract] [Full Text] [Related]

  • 10. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
    Yang Y, Macdonald GJ, Duggan KA.
    Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119
    [Abstract] [Full Text] [Related]

  • 11. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T.
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [Abstract] [Full Text] [Related]

  • 12. Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase.
    Kiss A, Jurkovicova D, Jezova D, Krizanova O.
    Endocr Regul; 2001 Jun; 35(2):65-70. PubMed ID: 11563933
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M, Konishi Y, Nishimura M, Umetani N, Iwai J, Negoro N, Inoue T, Takeda T, Kanayama Y.
    Blood Press Suppl; 1994 Jun; 5():75-8. PubMed ID: 7889207
    [Abstract] [Full Text] [Related]

  • 14. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M, Ohtsuka K, Sakamoto M, Nanbu A, Takahashi H, Yoshimura M.
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L, Sealey JE, Chen R, Zhou Y, Merali C, Shi Y, Laragh JH, Catanzaro DF.
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [Abstract] [Full Text] [Related]

  • 16. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS, Clark KL, Johns EJ, Drew GM.
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [Abstract] [Full Text] [Related]

  • 17. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
    K-Laflamme A, Foucart S, Moreau P, Lambert C, Cardinal R, de Champlain J.
    J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
    [Abstract] [Full Text] [Related]

  • 18. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S, Kadowitz PJ, Gurkan L, Chandra S, Dewitt SY, Harbin A, Sikka SC, Agrawal KC, Hellstrom WJ.
    BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
    [Abstract] [Full Text] [Related]

  • 19. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA, Paffaro VA, Pauli JR, da Silva GH, Saad MJ, Salgado I, da Cruz-Höfling MA, Hyslop S.
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [Abstract] [Full Text] [Related]

  • 20. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL, Giusti-Paiva A, Ventura RR, Margatho LO, Gomes DA, Elias LL, Antunes-Rodrigues J.
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.